Overview Financials News + Filings Key Docs Ownership Insiders
|
In millions, except per share items | Jan-31-23 | Jan-31-22 | Jan-31-21 | Jan-31-20 |
| 10-K | 10-K | 10-K | 10-K |
Revenues: |
UNITED STATES | 204.9 | 142.6 | 90.5 | 58.8 |
Non-US | 150.5 | 95.4 | 59.7 | 37.5 |
Total revenues | 355.4 | 238.0 | 150.2 | 96.4 |
Revenue growth [+] | 49.3% | 58.5% | 55.9% | |
UNITED STATES | 43.7% | 57.6% | 53.9% | |
Non-US | 57.8% | 59.9% | 59.0% | |
Cost of goods sold | 115.8 | 78.5 | 54.5 | 35.7 |
Gross profit | 239.6 | 159.5 | 95.7 | 60.7 |
Gross margin | 67.4% | 67.0% | 63.7% | 63.0% |
Selling, general and administrative [+] | 290.5 | 178.7 | 98.6 | 73.9 |
Sales and marketing | 201.7 | 127.1 | 70.7 | 57.3 |
General and administrative | 88.8 | 51.6 | 28.0 | 16.5 |
Research and development | 97.3 | 59.0 | 29.2 | 20.3 |
Other operating expenses | -1.2 | | | |
EBITDA [+] | -142.3 | -75.4 | -30.6 | -32.9 |
EBITDA growth | 88.7% | 146.8% | -7.1% | |
EBITDA margin | -40.0% | -31.7% | -20.3% | -34.1% |
Depreciation and amortization | 4.6 | 2.8 | 1.6 | 0.6 |
EBIT [+] | -146.9 | -78.2 | -32.2 | -33.5 |
EBIT growth | 87.9% | 143.3% | -4.1% | |
EBIT margin | -41.3% | -32.9% | -21.4% | -34.8% |
Non-recurring items [+] | 1.2 | | | |
Asset impairment | 1.2 | | | |
Interest income | 8.7 | 0.1 | 0.8 | 2.1 |
Interest income | 8.7 | 0.1 | 0.8 | 2.1 |
Other income (expense), net | -0.8 | -0.3 | -0.1 | 0.0 |
Pre-tax income | -140.2 | -78.3 | -31.4 | -31.4 |
Income taxes | 0.6 | -0.2 | 0.5 | 0.5 |
Tax rate | | 0.2% | | |
Net income | -140.7 | -78.2 | -32.0 | -31.8 |
Net margin | -39.6% | -32.8% | -21.3% | -33.0% |
|
Basic EPS [+] | ($1.49) | ($2.24) | ($1.78) | ($1.96) |
Growth | -33.6% | 25.9% | -9.5% | |
Diluted EPS [+] | ($1.49) | ($2.24) | ($1.78) | ($1.96) |
Growth | -33.6% | 25.9% | -9.5% | |
|
Shares outstanding (basic) [+] | 94.6 | 34.9 | 18.0 | 16.2 |
Growth | 171.0% | 94.2% | 11.0% | |
Shares outstanding (diluted) [+] | 94.6 | 34.9 | 18.0 | 16.2 |
Growth | 171.0% | 94.2% | 11.0% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|